Company Performance Metrics
DiaDeep is a French company that specializes in providing AI-driven diagnostic tools to help pathologists accurately quantify critical biomarkers in cancer diagnostics. Founded in 2022, DiaDeep focuses on improving the precision of cancer diagnostics, particularly for melanoma and breast cancer, through advanced algorithms that assist in the
analysis of pathology slides.
The company's technology is designed to support pathologists by enhancing their workflow and enabling them to make more confident and precise diagnostic decisions. DiaDeep emphasizes the role of pathologists in cancer treatment decisions, positioning its tools as a complement to their expertise. This approach aims to improve patient outcomes by ensuring that each diagnostic decision is supported by reliable, AI-enhanced data analysis.
DiaDeep’s products are particularly adept at handling various biomarkers such as Ki67, ER, PR, HER2, and PD-L1 (CPS and TPS scores), providing crucial insights that can bring efficiency for treatment strategies. The company values a close collaboration with healthcare providers, aiming to equip them with the necessary tools to improve diagnostic accuracy and patient care.
